← Oncology Approval Tracker

FDA DECISION ·

Imfinzi + platinum + etoposide

durvalumab + platinum chemotherapy + etoposide · AstraZeneca

FDA approvalNew or expanded indicationSmall cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First-line treatment for extensive-stage small cell lung cancer using durvalumab with etoposide and carboplatin or cisplatin.

LAMPGEN ANALYSIS

Why it matters

Added checkpoint blockade to a standard first-line chemotherapy backbone in extensive-stage disease.

What research teams should watch

Coordinate infusion sequencing and the transition to durvalumab maintenance.

PRIMARY RECORDS

Sources